Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3

Rhea-AI Summary

SS Innovations International, Inc. (OTC: SSII) is set to unveil its latest innovation in robotic surgery, the SSi Mantra-3 Surgical Robotic System, in New York City. This groundbreaking system, capable of featuring up to 5 robotic arms, will be demonstrated from July 23rd to 25th at the company's new showroom in the financial district. A live stream webcast will also be available on July 23rd for remote viewing.

The event will showcase the system's capabilities and offer insights into the future of surgical robotics. Key opinion leaders, including Dr. Frederic Moll and Dr. Vipul Patel, will be present to discuss the impact of the SSi Mantra-3. SS Innovations aims to make robotic surgery more affordable and accessible globally, with the SSi Mantra system already approved in India and undergoing regulatory processes in the US and EU.

Positive

• SSi Mantra-3 is the first unit of its kind with up to 5 robotic arms, potentially offering advanced surgical capabilities
• The system has received Indian Medical Device regulatory approval and is clinically validated in over 70 surgical procedures
• SS Innovations has commenced regulatory approval processes in the US and EU, anticipating FDA and CE Mark approvals in 2025
• The company aims to make robotic surgery more affordable and accessible globally

Negative

• The SSi Mantra system is not yet approved for use in the US or EU markets
• Regulatory approvals in the US and EU are not guaranteed and may face delays or rejections

New Disruptive System With The Potential To Bring Life-Saving Technology To Every Corner Of The Planet To Be Unveiled in New York For An Exclusive Demonstration

FORT LAUDERDALE, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra-3 Surgical Robotic System (“SSi Mantra) will be unveiled in New York City next week in an exclusive demonstration for media, analysts and the investment community.

The SSi Mantra 3, which is the first unit of its kind that can feature up to 5 robotic arms, will be available for viewing and an actual trial demonstration will be conducted daily from Tuesday, July 23rd through Thursday, July 25th from 12:00-1:30 pm ET at SS Innovations’ newly opened showroom located in the New York City financial district. For those that cannot attend in person, a live stream webcast will also be offered on July 23rd which can be registered for here:

https://www.ssinnovations.com/exclusive

This event will offer a unique opportunity to witness the next generation, disruptive SSI Mantra 3 Surgical Robotic System in operation and the surgical innovations it offers.

Event Highlights:

1. Live demonstrations of the SSI Mantra 3 Surgical Robotic System
2. Insights into the future of surgical robotics and our innovative solutions
3. Networking opportunities with industry experts and the SS Innovations Senior Executive Team
   

Key Opinion Leaders such as Dr. Frederic Moll, Dr. Vipul Patel, Dr. Husam Balkhy, Experienced Robotic Surgeons, and our Executive Team will be available to discuss the impact of the new SSi Mantra 3 and field questions from participants.

About SS Innovations International, Inc.:

SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra” its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII’s website at ssinnovations.com or LinkedIn for updates.

About SSI Mantra:

Supporting advanced, affordable, and accessible robotic surgery, the SSi Mantra Surgical Robotic System provides the capabilities for multi-specialty usage including cardiothoracic, head and neck, gynecology, urology, general surgery and more. With its modular arm configuration, 3D 4K vision open-console design and superior ergonomics, the system engages with the surgeon and surgical teams to improve safety and efficiency during procedures. The SSi Mantra system has received Indian Medical Device regulatory approval (CDSCO) and is clinically validated in India in more than 70 different types of surgical procedures. SS Innovations has commenced the regulatory approval process in the United States and the European Union and anticipates receiving FDA approval to market and CE Mark approval in 2025.

Forward-Looking Statements:

This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations International’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Follow us on:
LinkedIn: https://www.linkedin.com/company/ssinnovationsgroup/
YouTube: https://www.youtube.com/@ssinnovations

For media inquiries, please contact:
press@ssinnovations.org
+1-212-739-0300

FAQ

What is the SSi Mantra-3 Surgical Robotic System by SS Innovations (SSII)?

The SSi Mantra-3 is an innovative surgical robotic system developed by SS Innovations (SSII). It's the first of its kind that can feature up to 5 robotic arms, designed to make robotic surgery more affordable and accessible globally.

When and where will SS Innovations (SSII) demonstrate the SSi Mantra-3 system?

SS Innovations (SSII) will demonstrate the SSi Mantra-3 system from July 23rd to 25th, 2024, at their new showroom in New York City's financial district. A live stream webcast will also be available on July 23rd.

What regulatory approvals has the SSi Mantra system received as of July 2024?

As of July 2024, the SSi Mantra system has received Indian Medical Device regulatory approval (CDSCO) and is clinically validated in India. SS Innovations (SSII) has started the regulatory approval process in the US and EU, expecting FDA and CE Mark approvals in 2025.

What surgical specialties can the SSi Mantra Surgical Robotic System support?

The SSi Mantra Surgical Robotic System supports multi-specialty usage, including cardiothoracic, head and neck, gynecology, urology, general surgery, and more. It has been clinically validated in India for over 70 different types of surgical procedures.